openPR Logo
Press release

Investigation for Investors in shares of Progenity, Inc. (NASDAQ: PROG) announced

08-25-2020 01:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Progenity, Inc. (NASDAQ: PROG) shares over potential securities laws violations by Progenity.

An investigation for investors in Progenity, Inc. (NASDAQ: PROG) shares over potential securities laws violations by Progenity.

An investigation was announced on behalf of investors of Progenity, Inc. (NASDAQ: PROG) shares over potential securities laws violations by Progenity, Inc. in connection with certain financial statements.

Investors who purchased shares of Progenity, Inc. (NASDAQ: PROG), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Progenity, Inc. (NASDAQ: PROG regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. Progenity, Inc. reported that its annual Total Revenue rose from $127.97 million in 2018 to $143.98 million in 2019, and that its Net Loss increased from $129.10 million in 2018 to $148.03 million in 2019.
On or about June 6, 2020, Progenity sold about 6.7 million shares of stock in its initial public stock offering (the "IPO"), at $15.00 a share raising nearly $100.5 million in new capital.

However, since the IPO, Progenity stock declined to as low as $7.71 per share on August 14, 2020.

Those who purchased shares of Progenity, Inc. (NASDAQ: PROG) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in shares of Progenity, Inc. (NASDAQ: PROG) announced here

News-ID: 2120258 • Views:

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, Inc. (NYSE: DV)
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Progenity

Carrier Screening Market to Witness Phenomenal Growth | Major Giants GeneDx, Pro …
Latest research study released on the Global Carrier Screening Market by HTF MI Research evaluates market size, trend, and forecast to 2032. The Carrier Screening market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, CAGR, opportunities and upcoming challenges and about the competitors. Key
Rare Disease Testing Market Revenue, Key Findings and Forecast 2021-2026 | Preve …
The latest research report on the Rare Disease Testing Market by MarkNtel Advisors drafts an extensively detailed analysis of the different trends, drivers, restraints, challenges, and opportunities for the stakeholders to make informed decisions in the future. The report is to benefit the leaders by using the integrated market report using the advantageous information, including the impact of Covid-19. While the pandemic affected the world drastically and has brought along
Noninvasive Prenatal Testing (NIPT) Market to Witness Strong Growth by 2028 | Co …
Noninvasive Prenatal Testing (NIPT) Market research report identifies key market trends and focuses on the significant trends and factors driving the market growth. In addition, it analyses the global and key regions' market potentials and advantages, opportunities and challenges, restraints and risks. Finally, the Noninvasive Prenatal Testing (NIPT) Market research report strategically analyzes each submarket concerning market growth trends and their contribution. In addition, the Noninvasive Prenatal Testing (NIPT) Market
United States Non-Invasive Prenatal Testing Market Key Players Illumina, Natera, …
The United States Non-Invasive Prenatal Testing (NIPT) market is expected to touch a valuation of USD 2.5 Billion by 2028. The U.S. Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods
Investigation announced for Long-Term Investors in Progenity, Inc. (NASDAQ: PROG …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Progenity, Inc. Investors who are current long term investors in Progenity, Inc. (NASDAQ: PROG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: PROG stocks follows a lawsuit filed against Progenity, Inc. over alleged
Deadline on Oct. 27th coming up in Lawsuit for Investors in Progenity, Inc. (NAS …
A deadline is coming up on October 27, 2020 in the lawsuit filed for certain investors of Progenity, Inc. (NASDAQ: PROG) over alleged securities laws violations by Progenity, Inc. Investors who purchased shares of Progenity, Inc. (NASDAQ: PROG) have certain options and there are strict and short deadlines running. Deadline: October 27, 2020. NASDAQ: PROG stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the